Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism (Q42510897)

1 November 2017

Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism (English)

1 reference

1 November 2017

0 references

1 reference

2

1 reference

1 November 2017

3

Jannik Hilsted

1 reference

1 November 2017

Michael H Rasmussen

1

1 reference

PubMed ID

17426323

1 November 2017

language of work or name

1 reference

1 April 2007

1 reference

1 November 2017

1 reference

1 November 2017

15

1 reference

1 November 2017

4

1 reference

1 November 2017

879-886

1 reference

Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects

1 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Serum levels of insulin-like growth factor I and its binding proteins in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Effects of gastric bypass on the GH/IGF-I axis in severe obesity--and a comparison with GH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Free insulin-like growth factors in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Free insulin-like growth factor (IGF) in disorders of IGF binding protein 3 complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Insulin-like growth factors and their binding proteins: biological actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Insulinlike growth factor-binding protein proteolysis an emerging paradigm in insulinlike growth factor physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Contributions of gender and systemic estradiol and testosterone concentrations to maximal secretagogue drive of burst-like growth hormone secretion in healthy middle-aged and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Relationship between serum leptin and the insulin-like growth factor-I system in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

IGF-binding protein-4: biochemical characteristics and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and-3 and IGFBP-3 protease activity in boys with normal or precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Divergent Effects of Short-Term, Very-Low-Calorie Diet on Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 Serum Concentrations in Premenopausal Women with Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Ghrelin and the hyposomatotropism of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

A Specific Radioimmunoassay for the Growth Hormone (GH)-Dependent Somatomedin-Binding Protein: Its Use for Diagnosis of GH Deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

A simple assay for proteolysis of IGFBP-3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Insulin-like growth factor binding proteins in the human circulation: a review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.607

31 March 2020

Identifiers

DOI

10.1038/OBY.2007.607

1 reference

1 November 2017

1 reference

PubMed ID

17426323